Article ; Online: A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q).
2013 Volume 27, Issue 7, Page(s) 1610–1613
MeSH term(s) | Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/therapeutic use ; Biomarkers, Tumor/genetics ; Chromosome Deletion ; Humans ; Lenalidomide ; Middle Aged ; Myelodysplastic Syndromes/drug therapy ; Myelodysplastic Syndromes/genetics ; Peptide Hydrolases/genetics ; Polymorphism, Genetic/genetics ; Risk ; Thalidomide/analogs & derivatives ; Thalidomide/therapeutic use |
---|---|
Chemical Substances | Angiogenesis Inhibitors ; Biomarkers, Tumor ; CRBN protein, human ; Thalidomide (4Z8R6ORS6L) ; Peptide Hydrolases (EC 3.4.-) ; Lenalidomide (F0P408N6V4) |
Language | English |
Publishing date | 2013-02-26 |
Publishing country | England |
Document type | Letter ; Research Support, Non-U.S. Gov't |
ZDB-ID | 807030-1 |
ISSN | 1476-5551 ; 0887-6924 |
ISSN (online) | 1476-5551 |
ISSN | 0887-6924 |
DOI | 10.1038/leu.2013.59 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 2295: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.